- Home
- Healthcare professionals
- ACE Horizon Scanning
- Optune for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Brief
Optune for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Cancer
22 May 2023
Published on 22 May 2023
Last Updated on 22 May 2023
This Horizon Scanning Brief provides an assessment of Optune for the treatment of patients with newly diagnosed or recurrent glioblastoma.
Optune for the Treatment of Newly Diagnosed and Recurrent Glioblastoma [PDF, 1.2 MB]